Dermata Therapeutics (DRMA) Stock Chart & Stock Price History $0.67 0.00 (-0.15%) Closing price 07/3/2025 03:57 PM EasternExtended Trading$0.67 0.00 (0.00%) As of 07/3/2025 04:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Dermata Therapeutics Stock Price Performance The Dermata Therapeutics (DRMA) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 70.13%, with a year-to-date return of -50.67%. In the past month, the stock has decreased 5.93%, reflecting recent market activity. As of the latest close, Dermata Therapeutics traded at $0.67 with a market cap of $4.25 million and volume of 42,072 shares. Receive DRMA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Dermata Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+10.19%1 Month Performance-5.93%3 Month Performance-30.63%Year-To-Date Performance-50.67%1 Year Performance-70.13% DRMA Stock Chart for Friday, July, 4, 2025 DRMA Chart by TradingView Dermata Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/03/2025$0.67$0.67-0.15%$0.70$0.6542,072 shs$4.25 million07/02/2025$0.64$0.67+4.12%$0.69$0.6488,484 shs$4.26 million07/01/2025$0.59$0.64+9.50%$0.65$0.5968,315 shs$4.09 million06/30/2025$0.60$0.59-3.21%$0.63$0.5950,410 shs$3.73 million06/27/2025$0.59$0.60+3.14%$0.61$0.5981,564 shs$3.86 million06/26/2025$0.63$0.59-6.33%$0.63$0.57103,125 shs$3.74 million06/25/2025$0.63$0.63-0.70%$0.63$0.60110,893 shs$3.99 million06/24/2025$0.63$0.63-0.32%$0.65$0.61139,965 shs$4.02 million06/23/2025$0.68$0.63-6.48%$0.68$0.6361,676 shs$4.03 million06/20/2025$0.69$0.68-2.64%$0.68$0.66113,374 shs$4.31 million Get the Latest News and Ratings for DRMA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Dermata Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/19/2025$0.69$0.69$0.72$0.65132,909 shs$4.43 million06/18/2025$0.71$0.69-1.91%$0.72$0.65132,909 shs$4.43 million06/17/2025$0.70$0.71+1.09%$0.73$0.6847,329 shs$4.51 million06/16/2025$0.71$0.70-1.73%$0.71$0.6950,049 shs$4.47 million06/13/2025$0.73$0.71-2.96%$0.73$0.7032,711 shs$4.54 million06/12/2025$0.77$0.73-5.17%$0.79$0.73103,591 shs$4.68 million06/11/2025$0.75$0.77+3.20%$0.80$0.76111,682 shs$4.94 million06/10/2025$0.76$0.75-1.03%$0.80$0.7379,602 shs$4.78 million06/09/2025$0.75$0.76+1.70%$0.76$0.7199,183 shs$4.83 million06/06/2025$0.70$0.75+6.75%$0.75$0.6970,164 shs$4.75 million06/05/2025$0.71$0.70-1.41%$0.75$0.68183,151 shs$4.45 million06/04/2025$0.70$0.71+0.53%$0.73$0.66117,174 shs$4.52 million06/03/2025$0.70$0.70+0.61%$0.73$0.69101,413 shs$4.49 million Related Companies FLGC Stock Chart COCP Stock Chart PMN Stock Chart GELS Stock Chart BFRG Stock Chart ALLR Stock Chart VYNE Stock Chart RLYB Stock Chart ACXP Stock Chart PRPH Stock Chart Receive DRMA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Dermata Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:DRMA) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dermata Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dermata Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DRMA Stock Alerts